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We treated a 13-year-old boy for life-threatening self-injurious behavior (SIB) and severe
Kanner’s autism with deep brain stimulation (DBS) in the amygdaloid complex as well
as in the supra-amygdaloid projection system. Two DBS-electrodes were placed in both
structures of each hemisphere. The stimulation contacts targeted the paralaminar, the
basolateral (BL), the central amygdala as well as the supra-amygdaloid projection system.
DBS was applied to each of these structures, but only stimulation of the BL part proved
effective in improving SIB and core symptoms of the autism spectrum in the emotional,
social, and even cognitive domains over a follow up of now 24 months. These results,
which have been gained for the first time in a patient, support hypotheses, according to
which the amygdala may be pivotal in the pathogeneses of autism and point to the special
relevance of the BL part.
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SUMMARY
A 13-year-old boy suffering from severe Kanner’s autism and
life-threatening self-injurious behavior (SIB) was treated with
bilateral deep brain stimulation (DBS) in the amygdaloid com-
plex. The contacts of the DBS-electrodes were positioned in the
paralaminar, the basolateral (BL), and in the central nucleus (CE)
as well as in the supra-amygdaloid projection system, respectively.
DBS in the BL nucleus, but not in the other target areas, resulted
in substantial improvement of both SIB and autism-related symp-
toms. Significant improvement has been achieved in the domains
of social contact, affect modulation and nocturnal sleep. In addi-
tion, rudimentary speech has been initiated. These results point
to the BL as a relay station which would either modulate input
and output flow determining complex behaviors or represent a
crucial collection of cells which are compromised in autism by
unknown factors. It is intriguing, that DBS in the BL did not only
improve SIB and negative symptoms related to autism but obvi-
ously “released” social and cognitive functions which had been
suppressed before. For the first time we could demonstrate in a
human that:
• The amygdala has an important part in the etiopathogenesis of
autism and autism-related SIB
• The BL nucleus appears to be pivotal and
• DBS in the BL amygdala was effective and did not
evoke any side-effects, thus having the potential for treat-
ment of selected patients with severe Kanner’s autism and
related SIB.
INTRODUCTION
SIB is a devastating disorder with a high prevalence in indi-
viduals suffering from severe retardation. It is often associated
with autism. Prevalence estimates vary considerably, depending
on designs and inclusion criteria of individual studies but may
account for 5–10% of the mentally retarded population and at
about twice that rate among autistic persons (Borthwick-Duffy,
1994; Schroeder et al., 2001). Both, chronic severe SIB and autism
are extremely difficult to treat especially, if they manifest them-
selves in combination. So far, the most successful therapeutic
strategies have been based on behavioral techniques founded
on operant principles of learning/conditioning combined with
pharmacological treatment using neuroleptic drugs.
The amygdaloid complex is a prominent agglomeration
of nuclei and cortical regions in the medial temporal lobe
(Brockhaus, 1938; Yilmazer-Hanke, 2012). Based on histologi-
cal and histochemical differences, these areas are clustered into
three primary units: the BL, centromedial (Ce), and cortical
(superficial) parts.
Half a century ago, it had been shown that bilateral stereo-
tactic ablation of basal and cortico-medial amygdaloid nuclei
in patients with temporal epilepsy and aggressive behavior
improved aggressiveness considerably (Narabayashi et al., 1963;
Narabayashi and Uno, 1966; Narabayashi, 1970, 1979; Luczywek
and Mempel, 1976; Mempel et al., 1979). This demonstrated the
important role of the amygdala in the pathogenesis not only
of temporal epilepsy but also in emotional, especially in rage
processing.
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Sub-nuclei of the amygdaloid complex and especially their
intrinsic GABA-ergic and glutamatergic systems have recently
spurred interest in the field of autism-research (Rubenstein and
Merzenich, 2003; State, 2010). Plausible hypotheses have been
established, linking pathological bioelectrical activity in amyg-
daloid circuits with some of the most predominant features of the
autistic spectrum (Bachevalier, 1994, 2006; Baron-Cohen et al.,
2000; Amaral et al., 2003 as reviewed by Schumann et al., 2006;
Markram et al., 2008; Markram and Markram, 2010).
Here, we present the case of a now 14-year-old boy with
early-childhood autism, mental retardation, and conventionally
intractable SIB whom we have successfully treated with DBS in
the BL amygdala based on the mentioned pathophysiological
considerations.
For the first time, we demonstrate that DBS in the latter struc-
ture has the potential to markedly reduce SIB, and also to improve
features pertinent to the autistic syndrome, such as deficits in
social contacts, affect-modulation and speech, fear and anxiety
as well as sleep disorders.
BACKGROUND
PATIENT AND CASE HISTORY
Following a pregnancy without complications the patient was
born via section due to bleedings (placenta praevia). Genetic
investigations did not demonstrate any chromosomal or molec-
ular genetic abnormalities, no sign of fragile-x-syndrome and
no mutation of the MECP2-gene. Diagnostics of inborn errors
of metabolism, e.g., of Lesch–Nyhan syndrome, were also
inconspicuous.
The patient, at that time an 11-year-old autistic (Kanner’s
autism) and mentally retarded male youth with infantile cere-
bral palsy, was referred for treatment of SIB to the out-patient
unit of the Department of Child and Adolescent Psychiatry of
Cologne UniversityHospital. In the first years of his life occasional
complex partial and generalized epileptic seizures occurred which
were abolished completely by anti-epileptic medication.
The patient’s SIB had already developed in his infancy at age 3
and deteriorated severely and continuously during the last two
years before referral. Almost permanent restraint and around-
the-clock staff supervision became necessary to prevent severe
self-injury. As a result of permanent body restraint and infantile
cerebral palsy (severe spastic paraparesis of the lower extremities
and mild spasticity in the upper extremities) the boy had to use a
wheel-chair for years, thus becoming unable to stand freely or to
walk unaided.
Along with SIB, features characteristic for the autistic syn-
drome developed which added to compromising his condition
extremely. He was unable to communicate verbally, since lan-
guage development had failed. Except with his parents and his
elder brother, who is also suffering from Kanner’s autism, no
social interactions were possible. It was not feasible to estab-
lish eye contact. He did not exhibit any exploratory behavior
and suffered from progredient, eventually most severe anxiety
attacks, emotional tensions, and temper tantrums. Despite ade-
quate medication, nocturnal sleep was interrupted every 1–1.5 h
by prolonged periods of screaming and SIB which worsened the
social situation considerably.
The severity of the boy’s symptoms, especially his inabil-
ity to communicate and collaborate, precluded the applica-
tion of standard tests used for assessment of symptoms of the
autism spectrum (e.g., The Autism Diagnostic Observation Scale,
ADOS: (Lord et al., 2000), and the Social Responsiveness Scale;
SRS: Constantino and Gruber, 2005). Repeated observations
of the parent–child-interaction, behavioral monitoring at the
kindergarten as well as administering a specific autism-interview
(ADI-R; Lord et al., 1994) confirmed the diagnosis of Kanner’s
autism.
Initially, the patient was treated pharmacologically with neu-
roleptic drugs for preventing self-injury and to permit an at
least transient release from permanent restraint. At age 10, neu-
roleptic therapy was started with Risperidone® (maximal dose of
2mg/day). This successfully held at bay SIB for about two years.
With the boy entering puberty, aggression and SIB increased,
despite the administration of the maximally tolerated dose of
Risperidone®.
Since the therapy with Risperidone® obviously did not suffice,
medication was changed to Topiramate®, an anti-epileptic and
anti-migraine agent as well as a mood-stabilizer; maximum
dose of 200mg/day. This also failed to sufficiently reduce the
self-harming behavior. Therefore, the medication schedule was
abandoned again and replaced by a “third-generation” atypical
neuroleptic, Aripiprazole®, which was administered at 20 mg/day
and markedly reduced SIB for several weeks. Subsequently, fre-
quent episodes and outbursts of aggressive behavior recurred,
calling for additional sedative medication using benzodiazepines
(Lorazepam®) and permanent restraint to lessen self-injury.
In summer 2009, when the boy was 13-years-old, life-
threatening SIB could no longer be prevented or averted with
psychopharmacological treatment regimens and behavioral ther-
apy alone. At this point, neuromodulation using DBS in the
amygdaloid nuclei and the supra-amygdaloid projection system
was considered.
After having received informed consent by both parents as
well as a permit by the ethical committee (IRB) of the University
of Cologne, surgery was performed 10/23/2009 and DBS ini-
tiated. In addition to DBS, pharmacological treatment with
Aripiprazole® at 20mg/day was continued over the first year of
follow-up and gradually reduced thereafter.
ETHICAL IMPLICATIONS
The parents are court-approved guardians. It goes without say-
ing that they had been fully informed well in advance about the
experimental nature of this last resort treatment, about realis-
tic expectations and, in particular, about all conceivable risks of
DBS in the amygdala and the supra-amygdaloid projection sys-
tem. Since the amygdala has a low threshold for afterdischarges
induced by electrical stimulation (Akert, 1961; Falconer et al.,
1964), the possible risk of generating epileptic seizures by DBS
had been explained explicitly.
The fact, that this nuclear complex and its projection system
were proposed as targets for DBS for the first time was explained
in quite some detail in repeated talks with the parents.
IRB of the Medical Faculty of the University of Cologne had
been informed in considerable detail beforehand and granted
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consent to undertaking a so-called “Individueller Heilversuch.”
This legal term roughly translates into “individual attempt at
healing.” In a strict sense, under German law the consent to an
“individual attempt at healing” by the ethical committee would
not have been mandatory in conventionally untreatable disor-
ders like the one discussed here. An “Individueller Heilversuch”
precludes scientific evaluation. Thus, the treatment had been
performed just to improve the deleterious condition of the
patient. The permit to retrospectively analyze our data has been
given by our ethical committee in a late stage of follow-up on
our demand.
SURGERY
Targeting and trajectory planning was described elsewhere in
detail (Voges et al., 2002). For geometry-correction and land-
mark identification, a pre-operative MRI data set was obtained
with an 1.5 T Gyroscan Intera (Philips Medical Systems) scanner
equipped with SENSE-flex-M surface coils (imaging parame-
ters: T1-weighted, gradient echo, TR 31ms, TE 15ms, flip angle
40◦, three dimensional encoding, bandwidth 35Hz/pixel, field of
view 290mm, slice thickness 2mm, slice distance 2mm, matrix
512 × 512, stack of 70 slices) andwas fused with CT data obtained
immediately preoperatively with a stereotactic localizer attached
to the patient’s skull. Here, a Philips iCT 256 was used. Image
geometry was as follows: slice thickness 1.25mm, slice spacing
1.25mm, field of view 310mm, matrix 512 × 512. A total of 110
slices was recorded. In order to define the target-areas in more
detail, we applied a non-linear transformation of the delineations
of matching structures using the Atlas of the Human Brain by
Mai et al. (2008).
Under general anesthesia two quadripolar DBS-electrodes
(Medtronic Inc., model 3387 R) had been stereotactically
implanted bilaterally through precoronal burr holes into:
(1) The amygdaloid complex and
(2) The supra-amygdaloid projection system including the bed
nucleus of the stria terminalis, respectively.
The non-insulated alloy poles of the electrodes employed are
ring-shaped with a diameter of 1.27mm and a height of 1.5mm.
Four such contacts are stacked along the stimulation electrode in
a way that they are separated from each other by insulating spac-
ers being equally 1.5mm high. This electrode-/contact-geometry
permit’s stimulating a cylindrical volume with an approximate
maximum diameter of 4–5mm and an estimated length of
10.5mm. All four individual electrodes were fixed within their
respective burr holes with sutures and bone-compatible cement.
In the same session, they were subcutaneously connected to
impulse generators (IPG) (Medtronic Inc., “Activa PC®”) which
were bilaterally implanted in a pocket under the cutis over the
breast muscle.
TARGETING
Amygdala-electrodes
In humans, the precise targeting of amygdaloid subnuclei is
complicated by a quite marked degree of variability concern-
ing the locations of its components within the 3D-stereotactic
space as well as to their individual spatial relationships (Baird
et al., 1960; Oya et al., 2009). Hence, a sufficiently precise def-
inition of the targets of the electrode-contacts is not feasible in
terms of stereotactic coordinates. Instead, individual MRI-data
of each patient have to be matched with atlas templates (Löchel,
2007).
DBS targets were chosen in both hemispheres as to contact the
entire dorso-ventral extension of the deep (BL) nuclei, the supra-
amygdaloid region, comprising the lateral division of the CE and,
finally, the sublenticular area with the CH 4 group of cholinergic
cells and passing fibers.
Left electrode; positioning of stimulation contacts. Two contacts
were placed within the BL-amygdala: a first one, in the border
region between the ventral (paralaminar) and the BL nucleus
(Contact 0) and a second one (Contact 1) in the center of the
BL nucleus. Due to the presumably significant current spread,
depending as to strength and range on the stimulation parameters
used (McIntyre, 2011); the immediately adjacent parts of both the
lateral and basomedial nuclei might be affected likewise.
The third Contact (Contact 2) was placed within the most
lateral division of the CE.
Contact 3 was positioned in the sublenticular territory which
encompasses several poorly segregated major structures: the stri-
atopallidal amygdalofugal fibers, fibers related to the external
capsule, the uncinate fascicle as well as the magnocellular cholin-
ergic system of the forebrain and the extended amygdala (Alheid
and Heimer, 1988).
Right electrode; positioning of stimulation contacts. The right
electrode was positioned corresponding to the one on the left side,
but 2mmmore dorsally. Thus, Contacts 0 and 1 are placed within
the posterior part of the BL nucleus, Contacts 2 and 3 are located
in the sublenticular fiber system (Figure 1).
Electrodes in the supra-amygdaloid projection system
The distal pole (Contact 0) was positioned in the fasciculosus
nucleus of the thalamus (the primary target of fibers of the ventral
amygdalofugal pathway and the inferior thalamic peduncle).
Contact 1 targeted the rostro-dorsal border of the fasciculosus
nucleus/inferior thalamic peduncle.
Contact 2 was positioned in the supra-amygdaloid fiber system,
while
Contact 3 targeted the lateral part of the bed nucleus of the stria
terminalis which is a major projection area of the
central amygdala.
DOCUMENTATIONOF ELECTRODE LOCALIZATION
The correctness and precision of electrode placements at their
respective targets had been assessed with intra-and post-operative
stereotactic X-ray images, registered with the intra-operative
MRI data sets, according to which targeting and trajectory
planning had been performed. Nine months after implantation,
the precision of the electrode placement as well as the stability
of their positions have again been verified by a control CT, reg-
istered with the intra-operative planning-MRI and mapped onto
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FIGURE 1 | Image fusion of post-operation CT (nine months after
implantation) with T1-weighted intraoperative planning MRT
visualizing the actual electrode position in axial and coronal planes
(displayed image size: 145× 145mm). The active contacts are indicated
by red lines in the coronal section. (A) The coronal image is re-sliced in
order to show the electrode trajectory in the section plane. Arrowheads
indicate the trajectories of the supra-amygdaloid electrodes, which are not
activated. The active poles on the right electrode are located close to the
posterior part of the basolateral amygdaloid nucleus (Contact 0 and 1).
The active pole on the left electrode is positioned in the center of the
basolateral nucleus. (B) Horizontal section through the amygdala of both
hemispheres showing the electrodes indicated by arrows in the posterior
part of the basolateral nucleus immediately in front of the tip of the
temporal horn of the ventricle.
the atlas of the human brain (Mai et al., 2008) Using the vari-
ous data sets, we thus determined the most probable anatomic
position which was unchanged when compared to the immediate
post-operative control.
STIMULATION PARAMETERS, SITES, AND SCHEDULES
Since the boy’s deleterious condition required rapid improvement
and the functional relevance of the targeted substructures with
respect to SIB and autism was but speculative, three days after
surgery all four contacts of the amygdala—electrodes had been
activated simultaneously. This and subsequent additional stim-
ulation of the two proximal contacts of the supra-amygdaloid
electrodes which targeted the extended amygdala as well as
the bed nucleus of the stria terminalis, only led to insufficient
improvement.
We therefore restricted DBS, by successively eliminating ini-
tially active contacts, to those targeting the BL and the Ce nucleus.
It turned out that only stimulation over the contacts in the BL
amygdala (Contact 1 of the left and Contacts 0 and 1 of the right
amygdala-electrode) induced significant and stable improvement
of both SIB and symptoms pertinent to the autism spectrum.
Stimulation over the contacts targeting the CE nucleus was not
only inefficient, but appeared to even worsen the condition of the
patient.
Permanent DBS was performed with charge-balanced
electrical square wave pulses of 120µs duration, 130Hz pulse
following frequency and 2–6.5 Volts amplitude. Voltage was
slowly increased in the course of 12 months. Choosing a constant
frequency in this range has led to optimum results in the past in a
robust and reproducible way in the treatment of both motor and
several psychiatric disorders (Benabid et al., 1994, 2001, 2009;
Nuttin et al., 1999).
RESULTS
SELF-INJURIOUS BEHAVIOR (SIB)
The patient’s parents longitudinally monitored and documented
the behavior of their son in detail. The father developed an empir-
ical score of his own design to rate the degree of SIB, as indicated
by an ordinal scale from 6 (worst case) to 1 (best case), describ-
ing the extent of physical fixation required to control self-injury
inflicted by auto-aggression (1: no restraint necessary; 2: restraint
of the wrists suffices and is well tolerated; 3: restraint of the wrists
prevents self harm in an almost adequate manner; 4: restraint
of the wrists fails to completely control SIB; 5: restraint is not
sufficient to control SIB—however, skin lesions do not occur;
6: restraint does not prevent skin lesions and life threatening
self-injury). The score has been applied several times a week dur-
ing 6 months before surgery and during the entire follow-up
period.
However, this empirical score relied on subjective, day-to-
day impressions of the parents who did not command medical,
psychiatric, or psychological training.
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As becomes clear by the nature of the observable, this
general tool was made up devoid of statistical considerations,
or strict attempts at standardization. Therefore, we must not
take its results at face value, but have to consider biases intro-
duced by the parents, who were in the know about changes
in therapy. This also applies for the investigating child and
adolescent psychiatrists and neurosurgeons. In addition, we
should realize that this score is problematic when it comes to
quantification, since it rests on an ordinal scale. Hence, it is
rather an aid for recording observation than an instrument fit
for scoring the severity of specified symptoms or behavioral
patterns.
SIB and symptoms of the autism spectrum were assessed by
the child and adolescent psychiatrist at irregular intervals for two
years before and according to clinical necessities, at minimum at
three months’ intervals, after surgery. After 10 months of stimu-
lation the battery of the amygdala-IPG was depleted and the boy
was without stimulation for 4 weeks. Additional investigations
have been performed during the period without stimulation, as
well as 1 and 6 weeks, respectively, after exchanging the exhausted
IPG that supplied the amygdala-electrodes and resuming of DBS
and finally on January 24th, 2012.
Any of the pharmacological treatment schedules outlined
above were, at best, beneficial to improve SIB up to scores lower
than 6 but not lower than 4. In the final pre-operative phase of the
disorder, scores were constantly 6 for more than 8 weeks.
DBS in the amygdala resulted in a gradual, but very unstable
improvement of SIB over the first 10months after surgery to levels
lower than 3. During this period, the boy was—on occasion—able
to control his behavior for several hours usually followed by severe
attacks of SIB. In the 11th post-operative month DBS was inter-
rupted for 4 weeks because of depletion of the impulse generator’s
(IPG) battery.
The father rated his son’s behavior—before battery
depletion—with scores of 2–3. However, these scores con-
tinuously rose to 6 during the period without stimulation and
dropped to 2 one week and to 1–2 (no restraint required) six
weeks after re-starting DBS. At that time, DBS was restricted
to the BL nucleus. This score has been maintained since then.
Nevertheless, there still have been infrequent, less severe out-
bursts of SIB which rarely would last longer than up to 1.5 h
and usually have been triggered by unexpected changes in the
patient’s environment, common colds, etc.
The child and adolescent psychiatrist applied the Clinical
Global Impression (CGI)-Severity Scale (Guy, 1976) which is
specifically focused on target symptoms of irritability (aggression,
self-injury). The behavior was rated with a score of 6 (severely ill)
before surgery as well as without neurostimulation, i. e., when
the battery of the implanted stimulation device had failed due to
depletion, and with a score of 4 (moderately ill) one week and six
weeks, respectively, after DBS had been resumed following bat-
tery replacement. The behavior remained stable with a score of 4
during the subsequent 12 months until a final rating was done on
January, 24th, 2012, when the child and adolescent psychiatrist
visited the family at home for a behavioral observation (ADI-R
and CGI). The complete assessment of the degree of irritability
vs. time is shown in Display 1.
Having exchanged the IPG and resumed DBS, it took one
week until the CGI improved to a level of 4. This period was
interrupted by violent fluctuations of the patient’s condition.
These fluctuations were reduced after the supra-amygdaloid con-
tacts targeting the supra-amygdaloid fiber system—as well as the
bed nucleus of the stria terminalis—had been inactivated, result-
ing in a stabilized and continuing beneficial action of therapy
(Figure A1).
One week after resuming of DBS the (CE)-contacts had been
inactivated. Thereafter, the clinical state of the boy improved fur-
ther. This means that, according to the paternal rating, scores of
2 and even 1 were attained more frequently and remained sta-
ble for longer periods. Nevertheless, the CGI did not reach levels
below four, even with exclusive stimulation of the BL nucleus of
the amygdala.
FEATURES OF AUTISM
The ADI-R, a structured diagnostic interview suite (Lord
et al., 1994; Rutter et al., 2006), was used for assessing the
boy’s behavior on admission to the Department of Child and
Adolescent Psychiatry: Social Skills: 20; Non-verbal communi-
cation: 8; Restricted Repetitive and Stereotyped Behavior: 18.
Preoperatively, ADI-R—with respect to all scales—was also over
the threshold retrospectively assessed for the age of 4.0–5.0
years. This tool was re-applied post-operatively in January 2012,
i.e., 57 weeks after the restart of DBS. When ADI-R was actu-
ally measured at that time, the following post-operative values
were obtained (retrospective assessment at the age of 4.0–5.0
years are given in parentheses): Social Skills: 20 (20); Non-verbal
Communication: 7 (8); Restricted Repetitive and Stereotyped
Behavior: 13 (18). The most notable improvement was found
in Restricted Repetitive and Stereotyped Behavior. This improve-
ment was largely in concordance with the results of CGI that indi-
cated a decrease of irritability (aggressive behavior/self-injury)
from 6 (in the absence of DBS) to 4 (during DBS).
The child and adolescent psychiatrist noted an improvement
in self-regulatory skills in response to visual and auditory stimuli
and in the communicative eye contact with the examiner 6 weeks
after resuming neurostimulation. He based his report about the
behavior of the patient on the criteria of the “Autism Diagnostic
Interview-Revised” (ADI-R, Lord et al., 1994).
Already at that time, the patient’s parents reported that his
anxious behavior resulting from social contacts as well his emo-
tional tensions were reduced to a remarkable degree. Sleep was
normalized. The boy became able to participate in activities which
had been impossible before operation. He started venturing out
with his father, enjoying e.g., car rides. For instance, he became
able to actively explore and to play an electronic piano for up
to 30min. The parents also reported a remarkable improvement
of their difficulties to aliment their son. Before the period of
neurostimulation, the boy had avoided to explore new food and
accepted only a very limited repertoire of different edibles. After
restarting neurostimulation and restricting DBS to the (BL) the
parents observed that their son found pleasure in exploring new
and unknown food.
Surprisingly, after 6 months of stimulation, the parents
reported the utterance of single words such as “Papa” (daddy),
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“Mama” (mom), and “Hunger” (hungry) in the proper con-
text. Occasionally, when listening to pop music, he would join
the singer, pronouncing syllables of the refrain. The utterance of
words or comparable elements of language had been impossible
previous to the stereotactic procedure.
It was also observed by the parents and the child and ado-
lescent psychiatrist that the patient improved his skills to mod-
ulate his affects and moods after restarting neurostimulation
and restriction of DBS to the (BL). The abrupt shift of bal-
anced moods into aggressive behavioral traits was mitigated and
replaced by a more adapted behavior to social situations. This
improvement was documented in the behavioral observation
of social interaction by the child and adolescent psychiatrist.
Improvement was slow and interrupted by frequent recurrences
of the symptoms. It became significant and stable after restric-
tion of DBS to the BL nucleus by December, 2010. Since then
this status has remained unchanged with a continuing ten-
dency to further improvement. In February 2011, medication
with Aripiprazole® could be reduced from 20 to 10 mg/day and
Lorazepam® application even be discontinued.
DISCUSSION
DBS in the amygdala and its projection system has been used to
treat severe, life-threatening SIB in a 13-year-old boy, suffering
from Kanner’s autism and mental retardation.
During a follow-up period of 26months, not only SIB, but also
core symptoms of the autistic spectrum (fear and anxiety, emo-
tional tensions, sleep disorder, impaired self-regulatory processes
in response to auditory and visual stimuli, impaired affect mod-
ulation, and impaired communicative eye-contact) improved
gradually and have now reached their lowest levels. Language
development, not having occurred previously, was initiated or
disinhibited.
DBS in the supra-amygdaloid projection system, as well as
in the central and the paralaminar amygdaloid nucleus had
been ineffective, whereas restriction of the stimulation to the BL
nucleus yielded the described improvements.
We chose the amygdala and its projection system as target areas
because of the well-established role of this complex in rage pro-
cessing (Fernandez deMolina andHunsperger, 1959; Narabayashi
et al., 1963; Narabayashi and Uno, 1966; Narabayashi, 1970, 1979;
Luczywek and Mempel, 1976; Mempel et al., 1979) as well as
in fear (LeDoux, 2003)—and social processing, impairment of
which is believed to be central to autism (Baron-Cohen et al.,
2000; Amaral et al., 2003; Schumann et al., 2006; Santos et al.,
2011), and in relevance detection (Sander et al., 2003).
Before discussing our results we want to mention some caveats
which should be considered in the face of the favorable outcome:
as outlined in “Ethical implications” the treatment had to be
performed as “Individueller Heilversuch” (individual attempt at
healing) the purpose of which is just improvement of an other-
wise untreatable clinical condition and not scientific evaluation.
The permit to retrospectively analyze and publish our data has
been obtained from our IRB on our demand in a late stage of
follow-up.
Summing this up, no strict scientific investigational
design could be established beforehand, since all psychiatric
investigations and assessments had to be scheduled according
to clinical requirements, e.g., in cases, when SIB worsened or
a selected stimulation paradigm failed to improve a condition
insufferable for the patient. It is evident that the gravity of the
patient’s illness, making communication impossible, precluded
the application of standard tests for assessing the severity of
symptoms of both autism spectrum and SIB. Therefore, the
parental ratings and judgments which we considered very
trustworthy, had also to be accounted for. Hence, the only way
to clearly specify and communicate the behavioral abnormalities
encountered and their change in the course of DBS treatment
consisted in a thorough and detailed verbal description of our
observations.
Although what we denominated “positive effects” or “symp-
tomatic improvements” could not be rated by use of psychological
standard tests like the ADOS or ADI, we consider the descrip-
tions given here sufficiently reliable, since they were procured by
highly experienced Child and Adolescent Psychiatrists and addi-
tionally incorporated the important observations of the parents
in the patient’s domestic setting.
In this context, the rather difficult situation arising from the
fact that the patient could not be transferred to the hospital for
follow-up in the first year post-OP is of special importance. After
restricting the stimulation to the BL-Amygdala, the boy’s condi-
tion improved in such an unexpected way that we considered to
publish these retrospectively analyzed data with the consent of
our local ethical committee.
Despite the obvious shortcomings in the presentation of our
results being due to the circumstances described above, there
can be no doubt about the major improvements not only of SIB
but also of core symptoms of the autism spectrum caused by
DBS in the BL-Amygdala which, according to our point of view,
do merit publication, especially since this is the first attempt at
treating SIB associated with Kanner’s autism with DBS in the
Amygdala.
However, it should be noted that both investigating physicians
and observing parents could not be blinded to the treatment.
Biases cannot be excluded, but knowing the rather critical attitude
of the parents seems to us quite improbable.
STIMULATION PARAMETERS
The amygdaloid complex has not been addressed with DBS in
humans before. For the first attempt ever to do this, we delib-
erately used a simple stimulus protocol for the following reasons:
• There is as yet no standard procedure for establishing an opti-
mum parameter set for DBS stimulation of any deep brain
target.
• In addition, there is consensus that no current theory is able
to account for even the basic aspects of the mode of operation
of electrical extracellular neurostimulation viz. neuromodula-
tion, using multi-pole electrodes like those utilized in DBS in
humans.
With the abundance of unknown factors causative for
autism/SIB combined with a host of free parameters available
for setting neurostimulation, simple reasoning dictated using
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standard settings proven to be efficient in ameliorating move-
ment disorders (Benabid et al., 1994, 2001, 2009) as a first
approximation for subsequently identifying stimulus protocols
specifically aimed at obtaining favorable clinical outcomes with
DBS treatment of autism/SIB.
In this context, it should be noted that we raised stimulus volt-
age very cautiously, since it is well known that the amygdala has
a high propensity for LTP kindling (Racine, 1978) and a very
low threshold for generating repetitive discharges (Akert, 1961;
Falconer et al., 1964).
A frequently occurring, albeit transient clinical improvement
caused by local micro-lesions following the insertion into and
final positioning of DBS electrodes within other targets such as
the subthalamic nucleus did not occur in our case. This phe-
nomenon mimics actual electrostimulation at high frequencies
for a couple of days despite the electrode has not been acti-
vated yet, i.e., with the neurostimulator still in the “off” mode.
Therefore, its absence strongly speaks against the assumption that
the therapeutic effects had been caused by micro-lesions in the
case described here.
STIMULATION SITES
In view of these points, the amygdala may be considered a
key structure in the etiopathogenesis of autistic symptoms and
in mediating aggressive behavior. However, neither ablational
surgery nor functional imaging have sufficient spatial resolution
for correlating their results with the subnuclear organization of
the amygdala and associated areas. This makes it difficult to pre-
dict the consequences of stimulation of amygdaloid subnuclei
with respect to SIB and symptoms associated with autism.
In order to assess the specific amygdaloid areas stimulation of
which was likely to improve the boy’s symptoms, we implanted
the DBS electrodes bilaterally at two different sites. One elec-
trode targeted the paralaminar, the BL as well as the Ce nucleus
in order to modulate the input (L-BL) and successive processing
area (BL–Ce) of the amygdala. The trajectory of the other elec-
trode was destined to contact the extended amygdala in order to
interfere with efferent and afferent connections.
It turned out that only stimulation within the BL amyg-
dala improved the symptoms sufficiently, whereas stimulation of
any other target yielded minor and temporarily limited effects
at best. This finding strongly supports the assumption that the
area which has been stimulated effectively is functionally rele-
vant in the context of the treated disorder and that unspecific
effects due to possible mechanical irritation, microlesioning,
or inflammation presumably do not account for the observed
outcome.
The interpretation of the results of BL stimulation remains
tentative considering the complexity of the segregated circuits
connected through this structure which thus might have been
affected. Moreover, stimulation may not be restricted to the
BL nucleus but may also affect immediately adjacent parts
of the lateral and the basomedial nucleus, respectively, as a
result of current spread and stimulation of intermingling den-
dritic trees. These nuclei and their respective connections should
therefore also be considered when evaluating the effects of
stimulation.
The lateral nucleus is the main amygdaloid target for
already pre-processed multimodal information from higher order
association cortices (Pessoa andAdolphs, 2010). Subcortical affer-
ents reach the lateral nucleus predominantly from chemosensory,
visual, and auditory areas of the thalamus. Accordingly, the lateral
nucleus is involved in the processing and evaluation of sen-
sory stimuli reflecting emotional and socially pertinent content
(reviewed in Davis and Whalen, 2001; LeDoux, 2003).
Most of these fibers entering the lateral nucleus are glutamater-
gic and terminate on principal neurons that also use glutamate
as transmitter. These are under inhibitory control of different
classes of GABA-ergic interneurons (Lang and Pare, 1997, 1998;
Yilmazer-Hanke et al., 2007; Morozov et al., 2011). Their activity
plays a predominant role in balancing excitation and inhibition
within the lateral nucleus. An increase in excitatory tone resulting
from reduced GABAergic signaling might thus result in a hyper-
excitable state causing emotional tensions, rage, temper tantrums,
fear and anxiety, as well as cognitive dysfunctions (Harkin et al.,
1998; Hensch et al., 1998; Schuler et al., 2001), and—in extreme
cases—epileptic seizures. These states are major characteristics
comprising the autistic syndrome.
The BL nucleus is functionally interposed between the lat-
eral and CE and therefore regarded as a communication channel
between both nuclei (see Freese and Amaral, 2009). Besides its
afferents from the lateral nucleus it has major reciprocal connec-
tions with the orbitofrontal and the anterior cingulate cortex. The
concurrent processing of the input from these regions may be
regarded as a gate control system, where the “danger” signal, as
well as other emotionally and socially relevant signals, is evalu-
ated in the context of conscious experiences or expectations. Its
activity modulates the CE but also cortical areas that are involved
in the regulation of various cognitive functions (Phelps, 2006).
Hence, information propagation from cortex and subcortex
through the lateral to the BL nucleus is presumably modulated
by the above mentioned interaction between glutamatergic and
GABAergic chemical synaptic transmission thus being partic-
ularly relevant for autism. Genetic studies/genome scans have
revealed mutations in some patients with autism- associated
symptoms. These genetic changes affect the transmission of both,
GABA- and glutamatergic synapses (Hussman, 2001; Jamain
et al., 2002; Derwin´ska et al., 2009, reviewed by Rubenstein
and Merzenich, 2003; State, 2010). Reduced GABAergic sig-
naling of interneurons of the L and BL nuclei might yield a
“hyperexcitability-state” of the respective nuclei as found by
Markram et al. (2008) and reviewed by Markram and Markram
(2010) in the rat-valproic acid-model of autism and in con-
sequence impair both intraamygdaloid and amygdalo-cortical
circuitry. Thismight well contribute to the pathogenesis of autism
as proposed by the former authors and considering the well-
established role of the amygdala in rage processing also of SIB
and explain the beneficial effects of DBS in the BL nucleus which
have been achieved in our patient possibly through interference
of DBS at high frequencies with hyperexcitable cell ensembles in
the intra-amygdaloid relay-nucleus.
Nevertheless, when discussing a clinical case, i.e., a human
subject, we feel ethically obliged to duly take into account that
it remains controversial, whether neuroscientific results obtained
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from animal experimentation in phylogenetically rather primitive
species, especially in rodents with their simple brain architec-
ture and their rudimentary neocortex, are readily transferable to
apparently related conditions in the hypercomplex human brain,
as critically remarked by Markram et al. (2008; Markram and
Markram, 2010), although such results certainly do provide a
valuable starting point for future in-depth studies.
However, at this point we would like to indicate that the
reported results might not be restricted to the BL nucleus alone.
It is thoroughly conceivable that these beneficial effects are also
related to DBS-evoked modulations exerted by the BL nucleus
on a distributed network involving not only the amygdala, but
also other subcortical structures such as the striatum or other
basal ganglia. There are strong indications for efficient connec-
tivity between the striatum and the amygdala, as demonstrated
by Popescu et al. (2009) as well as for links with orbitofrontal
regions. Recently Le Jeune et al. (2010) have shown that DBS
in the subthalamic nucleus affects limbic and associative cir-
cuits. Furthermore, it was demonstrated that such modulations
were related to emotional disturbances (Péron et al., 2010).
Hence, these kinds of distant modulations, encompassing large-
scale network effects, might also have had an important part in
successfully treating the case reported here.
The improvement of core symptoms of autism by stimulation
of the BL amygdala supports hypotheses ascribing the amygdala
a dominant role in the pathogenesis of autism (Baron-Cohen
et al., 2000; Amaral et al., 2003 as reviewed by Bachevalier,
1994; Schumann et al., 2006; Markram et al., 2008; Markram
and Markram, 2010). We cannot exclude, however, that these
improvements might partly or even totally be due to psychosocial
alterations, caused by reducing SIB and/or pathological anxiety
through DBS.
Our finding that stimulation of other amygdaloid nuclei, espe-
cially of the CE as well as of the extended amygdala has been
ineffective is surprising and cannot be explained at present.
CONCLUDING REMARKS
We could show that the beneficial effects on both SIB and
symptoms of the autism spectrum were due to stimulation
of the BL-nucleus of the amygdala. However, long-range net-
work effects induced by DBS of this nucleus owing to the
strong connectivity between the amygdala and other deep
brain structures or orbitofrontal areas may also be assumed
as being causative for the positive clinical outcome reported
in this case study. Moreover, it cannot excluded that psycho-
social alterations caused by the reduction of SIB and anxiety
may also have contributed to the improvement of symptoms
of the autism spectrum The elucidation of their significance
in DBS treatment of autism/SIB will remain the objective of
future study.
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APPENDIX
FIGURE A1 | Changes of irritability [Clinical Global Impression Severity Scale (CGI)] and of core symptoms of autism (ADI-R) in the course of
treatment. The CGI-Severity Scale according to Guy (1976) is displayed here for addressing the target symptoms of irritability expressed by the patient during
the course of treatment. The scale has a range from 1 (normal) to 7 (extremely ill). Time point 0 corresponds to the initial onset of DBS. Arrows indicate
substantial changes induced by stopping (week 44) and restarting (week 48) DBS, respectively. After resuming DBS, CGI was constantly rated at 4
(moderately ill). The CGI was measured for the last time 59 weeks after restarting DBS treatment. CGI was determined on the same day when the ADI-R was
also assessed. ADI-R is included into this diagram for illustrative purposes.
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